DEUCRAVACITINIB LONG-TERM EFFICACY AND SAFETY IN PLAQUE PSORIASIS: 2-YEAR RESULTS FROM THE PHASE 3 POETYK PSO PROGRAM

被引：7

作者：

Warren, R. B. ^{[1
]}

Sofen, H. ^{[2
]}

Imafuku, S. ^{[3
]}

Szepietowski, J. ^{[4
]}

Blauvelt, A. ^{[5
]}

Spelman, L. ^{[6
]}

Colston, E. ^{[7
]}

Toms, J. ^{[8
]}

Buck, A. ^{[9
]}

Banerjee, S. ^{[10
]}

Menter, A. ^{[11
]}

机构：

[1] Univ Manchester, Dermatol, Manchester, Lancs, England

[2] UCLA, Dermatol, Sch Med, Los Angeles, CA USA

[3] Fukuoka Univ Hosp, Dermatol, Fukuoka, Japan

[4] Wroclaw Med Univ, Dermatol, Wroclaw, Poland

[5] Oregon Med Res Ctr, Dermatol, Portland, OR USA

[6] Verac Clin Res, Dermatol, Woolloongabba, Qld, Australia

[7] Bristol Myers Squibb, Dermatol, Princeton, NJ USA

[8] Bristol Myers Squibb, Clin Dev Dermatol, New Indicat, Princeton, NJ USA

[9] Bristol Myers Squibb, Biostats, Princeton, NJ USA

[10] Bristol Myers Squibb, Rheumatol & Dermatol, Princeton, NJ USA

[11] Baylor Univ, Med Ctr, Baylor Scott & White Hlth, Dermatol, Dallas, TX USA

来源：

关键词：

D O I：

10.1136/annrheumdis-2022-eular.2445

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

POS1046

引用

页码：841 / 841

页数：1